Multi‐epitope DNA vaccines (Q41604754)

5 October 2017

1 reference

title

Multi-epitope DNA vaccines (English)

1 reference

5 October 2017

Multi‐epitope DNA vaccines (English)

1 reference

18 November 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9315485

18 November 2024

DNA vaccine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9315485

18 November 2024

A. Suhrbier

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9315485

18 November 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9315485

18 November 2024

publication date

1 August 1997

1 reference

5 October 2017

August 1997

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9315485

full work available at URL

18 November 2024

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1038%2Ficb.1997.63

1 reference

http://www.nature.com/articles/icb199763

18 November 2024

1 reference

http://www.nature.com/articles/icb199763.pdf

18 November 2024

file format

Portable Document Format

1 reference

https://onlinelibrary.wiley.com/doi/pdf/10.1038/icb.1997.63

18 November 2024

1 reference

Immunology & Cell Biology

18 November 2024

published in

1 reference

5 October 2017

1 reference

5 October 2017

1 reference

5 October 2017

page(s)

402-408

1 reference

Recent advances in multiple antigen peptides

5 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

Epitopes on protein antigens: misconceptions and realities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

Opsonic human antibodies from an endemic population specific for a conserved epitope on the M protein of group A streptococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

Carrier sequence selection--one key to successful vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

HIV type 1 V3 region primer-induced antibody suppression is overcome by administration of C4-V3 peptides as a polyvalent immunogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

Presentation of a cytosolic antigen by major histocompatibility complex class II molecules requires a long-lived form of the antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

Minimal epitopes expressed in a recombinant polyepitope protein are processed and presented to CD8+ cytotoxic T cells: implications for vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

Expression of endogenous peptide-major histocompatibility complex class II complexes derived from invariant chain-antigen fusion proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

Subjugation of dominant immunogenic determinants within a chimeric peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

Peptide antigen production by the proteasome: complexity provides efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

Regulation of antigen processing and presentation to class I MHC restricted CD8+ T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

The cleavage preference of the proteasome governs the yield of antigenic peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

Immunostimulatory DNA sequences necessary for effective intradermal gene immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

Induction of single and dual cytotoxic T-lymphocyte responses to viral proteins in mice using recombinant hybrid Ty-virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

The law of mass action governs antigen-stimulated cytolytic activity of CD8+ cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

Immunological memory and protective immunity: understanding their relation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

Adjuvants for human vaccines--current status, problems and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

T cell priming versus T cell tolerance induced by synthetic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

Malignant lymphoma induction in rabbits by intravenous inoculation of Epstein-Barr-virus-related herpesvirus from HTLV-II-transformed cynomolgus leukocyte cell line (Si-IIA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

Burkitt's lymphoma cells are resistant to programmed cell death in the presence of the Epstein-Barr virus latent antigen EBNA-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

New treatment options for patients with melanoma: review of melanoma-derived T-cell epitope-based peptide vaccines.

21 January 2018

2 references

https://api.crossref.org/works/10.1038%2FICB.1997.63

21 January 2018

https://api.crossref.org/works/10.1038%2FICB.1997.63

7 January 2021

Human tumor antigens recognized by T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

Expression of MAGE genes in primary and metastatic cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucosaminyltransferase V gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

In vitro priming of cytotoxic T lymphocytes against poorly immunogenic epitopes by engineered antigen-presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

The pattern of cytokine gene expression in freshly excised human metastatic melanoma suggests a state of reversible anergy of tumor-infiltrating lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

Defective lymphokine production by most CD8+ and CD4+ tumor-specific T cell clones derived from human melanoma-infiltrating lymphocytes in response to autologous tumor cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

A case report: immune responses and clinical course of the first human use of granulocyte/macrophage-colony-stimulating-factor-transduced autologous melanoma cells for immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

Immune responses in HIV-exposed seronegatives: have they repelled the virus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

Cytotoxic T cells--protection from disease progression--protection from infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

Chemokine receptors: gateways to inflammation and infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

Evolution and plasticity of CTL responses against HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

Live-attenuated HIV vaccines: how safe is safe enough?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

The immune response to HIV: potential for immunotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

Type 1 cytokine production and low prevalence of viral isolation correlate with long-term nonprogression in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

Chemokines: leucocyte recruitment and activation cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

Progress towards a vaccine to prevent sexual transmission of HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

Long-lived cytotoxic T lymphocyte memory in mucosal tissues after mucosal but not systemic immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

Induction of human immunodeficiency virus type 1 (HIV-1)-specific cytolytic T lymphocyte responses in seronegative adults by a nonreplicating, host-range-restricted canarypox vector (ALVAC) carrying the HIV-1MN env gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

Polymerization of Unprotected Synthetic Peptides: A View toward Synthetic Peptide Vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

Free radical induced polymerization of synthetic peptides into polymeric immunogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

Correlates of protection in HIV infection and the progression of HIV infection to AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

CD8+ lymphocyte phenotype and cytokine production in long-term non-progressor and in progressor patients with HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

Antibody to hepatitis B surface antigen after a single inoculation of uncoupled synthetic HBsAg peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

Recognition of pre-processed endogenous antigen by class I but not class II MHC-restricted T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

Analysis of the immune response elicited by a Multiple Antigen Peptide (MAP) composed of two distinct protective antigens derived from the parasite Schistosoma mansoni

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

7 January 2021

A multivalent minigene vaccine, containing B-cell, cytotoxic T-lymphocyte, and Th epitopes from several microbes, induces appropriate responses in vivo and confers protection against more than one pathogen

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

7 January 2021

Protection against papillomavirus with a polynucleotide vaccine

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

7 January 2021

Regulation of house dust mite responses by intranasally administered peptide: transient activation of CD4+ T cells precedes the development of tolerance in vivo

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

7 January 2021

Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

7 January 2021

Functional analysis of amino acid residues encompassing and surrounding two neighboring H-2Db-restricted cytotoxic T-lymphocyte epitopes in simian virus 40 tumor antigen

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

7 January 2021

In vivo induction of cytotoxic T lymphocytes specific for a single epitope introduced into an unrelated molecule

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

7 January 2021

Antiviral protective immunity induced by major histocompatibility complex class I molecule-restricted viral T-lymphocyte epitopes inserted in various positions in immunologically self and nonself proteins.

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

7 January 2021

Vaccination to prevent persistent viral infection.

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

7 January 2021

Cytotoxic-T-lymphocyte responses to epitopes of listeriolysin O and p60 following infection with Listeria monocytogenes.

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

7 January 2021

Induction of protective cytotoxic T cells to murine cytomegalovirus by using a nonapeptide and a human-compatible adjuvant (Montanide ISA 720).

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

7 January 2021

Granulocyte-macrophage-colony-stimulating factor enhances immune responses to melanoma-associated peptides in vivo

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

7 January 2021

Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

7 January 2021

NYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

7 January 2021

Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

7 January 2021

Resistance to HIV-1 infection: it's in the genes

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

7 January 2021

Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

7 January 2021

Selective induction of immune responses by cytokines coexpressed in recombinant fowlpox virus.

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

7 January 2021

Rethinking AIDS and cancer

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.63

7 January 2021

A "string-of-beads" vaccine, comprising linked minigenes, confers protection from lethal-dose virus challenge

1 reference

Minimal determinant expressed by a recombinant vaccinia virus elicits therapeutic antitumor cytolytic T lymphocyte responses

18 November 2024

1 reference

18 November 2024

Identifiers

DOI

10.1038/ICB.1997.63

1 reference

Dimensions Publication ID

5 October 2017

1051333266

0 references

1 reference